A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report.


Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
31 Mar 2021
Historique:
received: 23 11 2020
accepted: 19 03 2021
entrez: 1 4 2021
pubmed: 2 4 2021
medline: 4 11 2021
Statut: epublish

Résumé

De novo pathogenic variants in the DDX3X gene are reported to account for 1-3% of unexplained intellectual disability (ID) in females, leading to the rare disease known as DDX3X syndrome (MRXSSB, OMIM #300958). Besides ID, these patients manifest a variable clinical presentation, which includes neurological and behavioral defects, and abnormal brain MRIs. We report a 10-year-old girl affected by delayed psychomotor development, delayed myelination, and polymicrogyria (PMG). We identified a novel de novo missense mutation in the DDX3X gene (c.625C > G) by whole exome sequencing (WES). The DDX3X gene encodes a DEAD-box ATP-dependent RNA-helicase broadly implicated in gene expression through regulation of mRNA metabolism. The identified mutation is located just upstream the helicase domain and is suggested to impair the protein activity, thus resulting in the altered translation of DDX3X-dependent mRNAs. The proband, presenting with the typical PMG phenotype related to the syndrome, does not show other clinical signs frequently reported in presence of missense DDX3X mutations that are associated with a most severe clinical presentation. In addition, she has brachycephaly, never described in female DDX3X patients, and macroglossia, that has never been associated with the syndrome. This case expands the knowledge of DDX3X pathogenic variants and the associated DDX3X syndrome phenotypic spectrum.

Sections du résumé

BACKGROUND BACKGROUND
De novo pathogenic variants in the DDX3X gene are reported to account for 1-3% of unexplained intellectual disability (ID) in females, leading to the rare disease known as DDX3X syndrome (MRXSSB, OMIM #300958). Besides ID, these patients manifest a variable clinical presentation, which includes neurological and behavioral defects, and abnormal brain MRIs.
CASE PRESENTATION METHODS
We report a 10-year-old girl affected by delayed psychomotor development, delayed myelination, and polymicrogyria (PMG). We identified a novel de novo missense mutation in the DDX3X gene (c.625C > G) by whole exome sequencing (WES). The DDX3X gene encodes a DEAD-box ATP-dependent RNA-helicase broadly implicated in gene expression through regulation of mRNA metabolism. The identified mutation is located just upstream the helicase domain and is suggested to impair the protein activity, thus resulting in the altered translation of DDX3X-dependent mRNAs. The proband, presenting with the typical PMG phenotype related to the syndrome, does not show other clinical signs frequently reported in presence of missense DDX3X mutations that are associated with a most severe clinical presentation. In addition, she has brachycephaly, never described in female DDX3X patients, and macroglossia, that has never been associated with the syndrome.
CONCLUSIONS CONCLUSIONS
This case expands the knowledge of DDX3X pathogenic variants and the associated DDX3X syndrome phenotypic spectrum.

Identifiants

pubmed: 33789733
doi: 10.1186/s13052-021-01033-4
pii: 10.1186/s13052-021-01033-4
pmc: PMC8011215
doi:

Substances chimiques

DDX3X protein, human EC 3.6.1.-
DEAD-box RNA Helicases EC 3.6.4.13

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81

Subventions

Organisme : Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
ID : RC 2019-2020
Organisme : Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
ID : PED-CARE-2018

Références

Biochem Pharmacol. 2010 Feb 1;79(3):297-306
pubmed: 19782656
EMBO Rep. 2019 Sep;20(9):e47498
pubmed: 31347257
Am J Med Genet A. 2019 Apr;179(4):570-578
pubmed: 30734472
Hum Mol Genet. 2016 Jul 15;25(14):2905-2922
pubmed: 27179789
Cell Rep. 2019 Jun 18;27(12):3573-3586.e7
pubmed: 31216476
Am J Hum Genet. 2015 Aug 6;97(2):343-52
pubmed: 26235985
PLoS One. 2013;8(3):e59445
pubmed: 23527197
Hum Genomics. 2018 Mar 1;12(1):11
pubmed: 29490693
Clin Dysmorphol. 2019 Oct;28(4):169-174
pubmed: 31274575
Neuron. 2020 May 6;106(3):404-420.e8
pubmed: 32135084
PLoS One. 2011 May 12;6(5):e19810
pubmed: 21589879

Auteurs

Giada Moresco (G)

Research Laboratories Coordination Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Jole Costanza (J)

Research Laboratories Coordination Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Carlo Santaniello (C)

Research Laboratories Coordination Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Ornella Rondinone (O)

Research Laboratories Coordination Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Federico Grilli (F)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Elisabetta Prada (E)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Simona Orcesi (S)

Child Neurology and Psychiatry Unit, IRCCS Mondino Foundation, Pavia, Italy.
Department of Brain and Behavioral Sciences, Università degli Studi di Pavia, Pavia, Italy.

Ilaria Coro (I)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Anna Pichiecchio (A)

Department of Brain and Behavioral Sciences, Università degli Studi di Pavia, Pavia, Italy.
Neuroradiology Department, IRCCS Mondino Foundation, Pavia, Italy.

Paola Marchisio (P)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.

Monica Miozzo (M)

Research Laboratories Coordination Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Health Science, Università degli Studi di Milano, Milan, Italy.

Laura Fontana (L)

Research Laboratories Coordination Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. laura.fontana@unimi.it.
Department of Health Science, Università degli Studi di Milano, Milan, Italy. laura.fontana@unimi.it.

Donatella Milani (D)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH